Indeed, the CB1R agonist activity of THC mimics endogenous cannabinoid signaling, which is notably downregulated in women with clinical depression (39), and endogenous cannabinoids appear to regulate neural serotonergic signaling (40). This evidence concerns the gene CNR1 and major depressive disorder.